Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour (Q42983370)

12 November 2017

Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour (English)

1 reference

12 November 2017

human papillomavirus 16

1 reference

2

1 reference

12 November 2017

Alexander A. Khromykh

series ordinal

3

1 reference

12 November 2017

Karen A Herd

1

1 reference

12 November 2017

Robert W Tindle

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

12 November 2017

1 reference

12 November 2017

319

1 reference

12 November 2017

2

1 reference

12 November 2017

237-248

1 reference

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Cytotoxic T cell polyepitope vaccines delivered by ISCOMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Sequence variation in the capsid protein genes of human papillomavirus type 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Cancer therapy using a self-replicating RNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

Papillomaviruses and cancer: from basic studies to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

7 January 2021

Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

7 January 2021

RNA-RNA recombination in Sindbis virus: roles of the 3' conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

7 January 2021

Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.032

7 January 2021

10.1016/J.VIROL.2003.10.032

Identifiers

DOI

1 reference

12 November 2017

1 reference